Wright Medical ramps up reps
This article was originally published in The Gray Sheet
Executive Summary
Wright's commissioned independent sales force likely will grow by 20% to 380 reps, the company says during Q4 earnings call. The larger sales force will help launch Wright's Conserve Plus femoral surface replacement system after approval. The firm awaits a PMA panel appointment; FDA nixed April as an option, leaving potential dates in July and October. Despite the uncertainty, Wright anticipates being first to market in the U.S. (1"The Gray Sheet" Dec. 13, 2004, p. 15). The manufacturer recorded sales of $77.7 mil. for Q4, up 13%. Overall, in 2004, sales increased 20% to $297.5 mil. The company anticipates sales exceeding $333 mil. in 2005...